[Health economics evaluations are of great significance for Pharmaceutical Benefit Board's decisions].
Persson
Ulf
U
Institutet för hälso- och sjukvårdsekonomi (IHE), Lund. up@ihe.se
Ramsberg
Joakim
J
D002017:Budgets; D003362:Cost-Benefit Analysis; D003661:Decision Support Techniques; D016527:Drug Costs; D004345:Drug Industry / Q000191:economics; D016568:Drugs, Generic / Q000191:economics; D004470:Economics, Medical; D017408:Guidelines as Topic; D006801:Humans; D010606:Pharmacy and Therapeutics Committee; D012051:Reimbursement Mechanisms; D013548:Sweden
D016568:Drugs, Generic